论文部分内容阅读
目的:探讨和分析孕期补钙对孕妇妊娠期高血压的预防效果。方法:随机选择自2012年6月~2013年1月期间,在我院妇产科进行产前检查和分娩的孕产妇174例,根据孕妇意愿将其分为平均的两组(观察组和对照组),每组各有孕妇87例。对对照组孕妇采用常规保健干预方法进行孕期护理,对观察组孕妇采用常规保健+孕期补钙方法进行护理,并就两组孕妇妊娠期的缺钙情况和妊娠期高血压发生率情况进行统计、分析和比较。结果:两组孕妇在经过科学、规范的护理后,观察组孕妇共有9例出现缺钙情况,总缺钙率为10.34%;对照组孕妇共有45例出现缺钙情况,总缺钙率为51.72%,观察组各项指标均明显低于对照组,组间比较均存在统计学意义(P<0.05)。观察组孕妇的妊娠期高血压发生率为2.30%(2/87),胎儿生长受限率为3.45%(3/87);对照组孕妇的妊娠期高血压发生率为19.54%(17/87),胎儿生长受限率为21.84%(19/87),观察组明显低于对照组,组间比较具有显著性差异(P<0.05)。结论:在孕期实施补钙措施,能够有效的抑制孕妇妊娠期高血压的发生,提高胎儿生存质量。
Objective: To investigate and analyze the preventive effect of calcium supplement during pregnancy on gestational hypertension in pregnant women. Methods: From June 2012 to January 2013, 174 pregnant women undergoing prenatal examination and childbirth were randomly selected in our department of obstetrics and gynecology. According to the wishes of pregnant women, they were divided into two groups (observation group and control group Group), each group of 87 pregnant women. The pregnant women in the control group were treated with routine health care interventions during pregnancy, and the pregnant women in the observation group were treated with regular health care and calcium supplementation during pregnancy. The incidence of calcium deficiency during pregnancy and gestational hypertension were calculated. Analysis and comparison. Results: After two groups of pregnant women after scientific and standardized care, a total of 9 cases of pregnant women in the observation group had calcium deficiency, with a total calcium deficiency rate of 10.34%. In the control group, 45 cases of calcium deficiency occurred in pregnant women with a total calcium deficiency rate of 51.72 %, The indicators of the observation group were significantly lower than the control group, there were statistically significant between the two groups (P <0.05). The incidence of gestational hypertension in observation group was 2.30% (2/87), and the rate of fetal growth restriction was 3.45% (3/87). The incidence of gestational hypertension in control group was 19.54% (17/87 ), Fetal growth restriction rate was 21.84% (19/87), the observation group was significantly lower than the control group, there was significant difference between the groups (P <0.05). Conclusion: The implementation of calcium measures during pregnancy, can effectively inhibit the occurrence of pregnancy-induced hypertension and improve fetal quality of life.